Healthcare stocks are an attractive prospect right now. Nearly 18% of the U.S. GDP went toward healthcare in 2021, which will only continue growing as the
While 2019 has not been a strong year for healthcare stocks, companies experiencing rapid sales growth – such as some select medical device companies – could
With unreasonably high valuations, increasing risks and fading momentum, the bull market in medical devices may be coming to an end soon. For those seeking
With a promising cannabinoid pipeline, an alternative to the EpiPen, and a superior solution for opioid overdoses, this firm has moved in on not one but three
